A carregar...
P12. Long term treatment with erlotinib in advanced non-small cell lung cancer patients
BACKGROUND: Erlotinib is nowadays an established treatment for metastatic non-small cell lung cancer (NSCLC) patients with tumours harbouring epidermal growth factor receptor (EGFR) activating mutations. After a year of initial treatment most patients progress, but some very long responses have been...
Na minha lista:
| Publicado no: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Pioneer Bioscience Publishing Company
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367785/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB024 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|